Iodide

Iodide

SCHEMBL6132319

C[N+]1(CCO)CCC(=O)CC1.[I-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.41
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
KMT2A Q03164 1/20 0.32
BBOX1 O75936 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10256575 0.77
SCHEMBL4893881 0.75 SLC18A3 (0.47) SLC18A3BBOX1
Iodide SCHEMBL426332 0.75 CHRNA10 (0.33)
Iodide SCHEMBL25405847 0.74 KDM4E (0.50) SLC18A3ALDH1A1HPGDKMT2ABBOX1
Iodide SCHEMBL14778907 0.72 KDM4E (0.54) SLC18A3ALDH1A1HPGDKMT2ABBOX1
SCHEMBL739073 0.72 TRIM24 (0.32) ALDH1A1
SCHEMBL8346719 0.71 BBOX1 (0.34) BBOX1
SCHEMBL3817323 0.71
SCHEMBL25557911 0.71
Bromide SCHEMBL4087944 0.70 TRIM24 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884868-B1 Cyclic hexapeptides having antibiotic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-04-26 US disclosed
EP-1173472-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-01-23 EP disclosed
WO-2000064927-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 WO disclosed